Cargando…

Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting

BACKGROUND: Down's syndrome is an important congenital chromosomal disorder that can be seen around the world. The antenatal screening for this disorder is an important processing in present obstetrics. OBJECTIVE: Due to the concept of first do no harm, the use of noninvasive test is recommende...

Descripción completa

Detalles Bibliográficos
Autor principal: Wiwanitkit, Viroj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228566/
https://www.ncbi.nlm.nih.gov/pubmed/25400343
http://dx.doi.org/10.4103/0971-6866.142880
_version_ 1782344009173172224
author Wiwanitkit, Viroj
author_facet Wiwanitkit, Viroj
author_sort Wiwanitkit, Viroj
collection PubMed
description BACKGROUND: Down's syndrome is an important congenital chromosomal disorder that can be seen around the world. The antenatal screening for this disorder is an important processing in present obstetrics. OBJECTIVE: Due to the concept of first do no harm, the use of noninvasive test is recommended. The triple marker screening test has been introduced for a few years and acceptable for its efficacy. RESULT: However, an important concern is on its cost-effectiveness. Here, the author analyze and present the cost-effectiveness of the triple markers serum screening for Down's syndrome in Thai setting. CONCLUSION: According to this work, the cost per effectiveness of triple markers serum screening is slightly lower than standard amniocentesis test.
format Online
Article
Text
id pubmed-4228566
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42285662014-11-14 Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting Wiwanitkit, Viroj Indian J Hum Genet Original Article BACKGROUND: Down's syndrome is an important congenital chromosomal disorder that can be seen around the world. The antenatal screening for this disorder is an important processing in present obstetrics. OBJECTIVE: Due to the concept of first do no harm, the use of noninvasive test is recommended. The triple marker screening test has been introduced for a few years and acceptable for its efficacy. RESULT: However, an important concern is on its cost-effectiveness. Here, the author analyze and present the cost-effectiveness of the triple markers serum screening for Down's syndrome in Thai setting. CONCLUSION: According to this work, the cost per effectiveness of triple markers serum screening is slightly lower than standard amniocentesis test. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4228566/ /pubmed/25400343 http://dx.doi.org/10.4103/0971-6866.142880 Text en Copyright: © Indian Journal of Human Genetics http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Wiwanitkit, Viroj
Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
title Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
title_full Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
title_fullStr Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
title_full_unstemmed Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
title_short Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting
title_sort cost-effectiveness analysis for triple markers serum screening for down's syndrome in thai setting
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228566/
https://www.ncbi.nlm.nih.gov/pubmed/25400343
http://dx.doi.org/10.4103/0971-6866.142880
work_keys_str_mv AT wiwanitkitviroj costeffectivenessanalysisfortriplemarkersserumscreeningfordownssyndromeinthaisetting